Use of MS Drug, Gilenya (Fingolimod), Expanded to Include Children

MONDAY, May 14, 2018 — The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.
It’s the first multiple sclerosis drug approved for children, the…
Source: Topamax